Evidence map›Paper›PMID 31792888›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2020

Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.

Chao Song, Tianwei Chen, Lan He, Ning Ma, Jian-Ang Li, Ye-Fei Rong, Yuan Fang, Mengmeng Liu, Dong Xie, Wenhui Lou

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Chao SongDepartment of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Tianwei ChenLaboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Rd., Shanghai, 200031, China.
Lan HeSchool of Life Science and Technology, Shanghai Tech University, Shanghai, 201210, China.
Ning MaLaboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Rd., Shanghai, 200031, China.
Jian-Ang LiDepartment of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Ye-Fei RongDepartment of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yuan FangDepartment of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Mengmeng LiuDepartment of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, 20032, China.
Dong XieLaboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Rd., Shanghai, 200031, China. dxie@sibs.ac.cn.
Wenhui LouDepartment of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. lou.wenhui@zs-hospital.sh.cn.
Fudan University · CNShanghai Institutes for Biological Sciences · CNZhongshan Hospital · CNShanghaiTech University · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors would like to correct the following panels in Figures.

Identifiers

PMID31792888
PMCPMC12990704
OpenAlexW2993522393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.